Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC

Leuven, Belgium - On June 4, 2025, Oxurion NV, a biopharmaceutical company listed on Euronext Brussels, announced that it has received a transparency notification. This step is in compliance with Belgian transparency legislation. The notification, dated June 3, 2025, comes from Atlas Special Opportunities II LLC. It indicates that as of May 30, 2025, Atlas held 244,798 shares of Oxurion's 6,156,035 existing shares, thus falling below the 5% ownership threshold due to the sale of voting securities.

This press release does not constitute an offer to sell Oxurion securities. The company emphasizes that certain statements may be considered future projections and are subject to various risks and uncertainties.